This association does not exclude the potential of PMCA2 as a drug target in some breast cancer cells, either via the previously proposed mechanism of promotion of apoptosis through PMCA2 inhibition19 and/or the anti-proliferative effects of PMCA2 inhibition identified in MDA-MB-231 cells in this study. Here, ATP2B2 is linked to breast cancer.